ANDREW C. VON ESCHENBACH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Lineage Cell Therapeutics, Inc.

Filing Date Source Excerpt
2012-04-30 Andrew C. von Eschenbach, M.D., 70, joined our Board of Directors during November 2011. ... The members of our Audit Committee are Arnold I. Burns, Abraham E. Cohen, and Pedro Lichtinger. ... Andrew C. von Eschenbach received total compensation of $69,952 in 2011.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22